Medical Therapies Ltd

Medical Therapies Limited is an Australian pharmaceutical company that has been formed to commercialise Australian medical discoveries. In exchange for a substantial shareholding in the company, the University of Sydney has assigned to Medical Therapies a valuable portfolio of a number of ground-breaking pharmaceutical compounds it has discovered and developed over the last 10 years. These patent-protected compounds offer the potential for substantially less toxicity in the treatment of inflammatory diseases such as arthritis and a new way to treat various cancers including skin cancer. Inflammatory disease and cancer represent two of the world's biggest medical markets, with sales of US$11 billion and US$57 billion estimated in 2006 ( www.medicaltherapies.com.au )